Einloggen

Thematische Bibliographien / Doran Company / Zeitschriftenartikel

Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Doran Company.

Zeitschriftenartikel zum Thema „Doran Company“

Autor: Grafiati

Veröffentlicht am 28. Juli 2024

Zuletzt aktualisiert am 31. Juli 2025

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Doran Company" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Doran, John, and John Donnelly. "Interview with John Doran." Talent & Technology 01, no. 03 (2007): 19–21. http://dx.doi.org/10.2118/0103-19-tt.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

2

Doran, John, and John Donnelly. "Interview with John Doran." Talent & Technology 01, no. 03 (2007): 19–21. http://dx.doi.org/10.2118/0103-19-tt.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

3

Barley, Diane. "How to Write for Moving Pictures: A Manual of Instruction and Information, Marguerite Bertsch (1917)." Journal of Screenwriting 11, no. 3 (2020): 388–90. http://dx.doi.org/10.1386/josc_00043_5.

Der volle Inhalt der Quelle

Annotation:

Review of: How to Write for Moving Pictures: A Manual of Instruction and Information, Marguerite Bertsch (1917) New York: G. H. Doran Company, 268 pp., ISBN 978-13-40460-04-4, h/bk, £20.79 ISBN 978-13-77165-03-5, p/bk, £15.99

APA, Harvard, Vancouver, ISO und andere Zitierweisen

4

Bogdańska, Olga, Verónica D’Auria, Coen Heijes, and Xenia Georgopoulou. "Theatre Reviews." Multicultural Shakespeare: Translation, Appropriation and Performance 10, no. 25 (2013): 133–52. http://dx.doi.org/10.2478/mstap-2013-0010.

Der volle Inhalt der Quelle

Annotation:

The Tempest. Dir. Silviu Purcarete. The National Theatre “Marin Sorescu” of Craiova, Romania. 16th Shakespeare Festival, Gdansk, Poland  Richard III. Dir. Gabriel Villela. Blanes Museum Garden, Montevideo, Uruguay Henry V. Dir. Des McAnuff. Stratford Shakespeare Festival, Ontario, Canada Julius Caesar. Dir. Gregory Doran. Royal Shakespeare Company A Midsummer Night’s Dream. Adapted and dir. Georgina Kakoudaki. Theatre groups _2 and 4Frontal, Theatro tou Neou Kosmou, Greece Julius Caesar: Scripta Femina. Dir. Roubini Moschochoriti. Theatre group Anima Kinitiras Stu

APA, Harvard, Vancouver, ISO und andere Zitierweisen

5

Huertas Martín, Víctor. "The Tempest de William Shakespeare, dirigida por Gregory Doran (Royal Shakespeare Company, 2016-2017). Dialéctica entre tecnología virtual y corporalidad." Diablotexto Digital 3 (January 18, 2019): 43. http://dx.doi.org/10.7203/diablotexto.3.13015.

Der volle Inhalt der Quelle

Annotation:

Este artículo estudia la dialéctica que se da entre los cuerpos de los actores y la tecnología virtual en la producción de The Tempest de Gregory Doran (2016-2017). Dicha dialéctica será observada desde una óptica marxista – principalmente a partir del trabajo de Silvia Federici – y desde la crítica textual y escénica del texto de Shakespeare. Aspectos como la tecnología y el cuerpo serán de importancia para mi trabajo. Particularmente me centraré en el cuerpo como materia sometida al castigo corporal y a su instrumentalización en la película. También trabajaré a partir de la teorización de Ga

APA, Harvard, Vancouver, ISO und andere Zitierweisen

6

Gregório, Paulo da Silva. ""Hamlet" na televisão: interfaces entre palco e tela." Letras, no. 63 (December 6, 2022): 112–26. http://dx.doi.org/10.5902/2176148555196.

Der volle Inhalt der Quelle

Annotation:

Várias produções britânicas de peças de Shakespeare para a televisão foram adaptadas de montagens teatrais. Essas adaptações do tipo palco-para-TV exploram elementos teatrais, televisivos e cinemáticos por meio de cuja combinação as performances ganham sentido na telinha. Este artigo investiga traços distintivos desse tipo específico de adaptação shakespeariana. Dando ênfase a uma adaptação televisiva de Hamlet a qual adaptou uma montagem teatral dirigida por Gregory Doran na Royal Shakespeare Company (2008), discutirei os mecanismos de intermedialidade e os processos de remediação a partir do

APA, Harvard, Vancouver, ISO und andere Zitierweisen

7

Rogers, Jami. "Review ofCardenio(directed by Gregory Doran for the Royal Shakespeare Company) at the Swan Theatre, Stratford-upon-Avon, 28 April 2011." Shakespeare 8, no. 2 (2012): 255–57. http://dx.doi.org/10.1080/17450918.2012.679307.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

8

Kirwan, Peter. "Review of Shakespeare'sTwelfth Night(directed by Gregory Doran for the Royal Shakespeare Company) at the Courtyard Theatre, Stratford-upon-Avon, 10 November 2009." Shakespeare 6, no. 2 (2010): 246–49. http://dx.doi.org/10.1080/17450911003790224.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

9

Kirwan, Peter. "Review of Shakespeare'sA Midsummer Night's Dream(directed by Gregory Doran for the Royal Shakespeare Company) at the Courtyard Theatre, Stratford-upon-Avon, August 2008." Shakespeare 4, no. 4 (2008): 455–58. http://dx.doi.org/10.1080/17450910802501238.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

10

Kirwan, Peter. "Review of Shakespeare'sRichard II(directed by Gregory Doran for the Royal Shakespeare Company) at the Royal Shakespeare Theatre, Stratford-upon-Avon, 29 October 2013." Shakespeare 10, no. 2 (2014): 197–200. http://dx.doi.org/10.1080/17450918.2014.885071.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

11

Martinez, Aurora Faye. "Review of Shakespeare'sHenry V(directed by Gregory Doran for the Royal Shakespeare Company) at the Royal Shakespeare Theatre, Stratford-upon-Avon, 28 September 2015." Shakespeare 12, no. 3 (2016): 331–32. http://dx.doi.org/10.1080/17450918.2016.1141794.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

12

Price, Eoin. "Review of Thomas Dekker, William Rowley and John Ford'sThe Witch of Edmonton(directed by Gregory Doran for the Royal Shakespeare Company) at the Swan Theatre, Stratford-upon-Avon, 7 November 2014." Shakespeare 11, no. 4 (2015): 459–60. http://dx.doi.org/10.1080/17450918.2015.1036909.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

13

Higgins, Laura. "Review of Shakespeare’s King Lear (directed by Gregory Doran for the Royal Shakespeare Company) at the Royal Shakespeare Theatre, Stratford-upon-Avon, 29 September 2016, and the Barbican Theatre, London, 21 November 2016." Shakespeare 13, no. 2 (2017): 180–83. http://dx.doi.org/10.1080/17450918.2017.1313304.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

14

Raby, Julie. "Review of Shakespeare'sHenry IV Parts OneandTwo(directed by Gregory Doran for the Royal Shakespeare Company) at the Royal Shakespeare Theatre, Stratford-upon-Avon, 23 August 2014, Theatre Royal Newcastle, 1 October 2014 and Lowry, Manchester, 22 October 2014." Shakespeare 11, no. 3 (2015): 325–27. http://dx.doi.org/10.1080/17450918.2015.1048285.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

15

Shodikin, King Amil Hamzah Al Hakim. "Efforts to Improve Public Awareness of the Environment through Empowerment-Based CSR Program Activities (Case Study: Donan Village, Cilacap Regency)." Radiant 5, no. 3 (2025): 241–54. https://doi.org/10.52187/rdt.v5i3.294.

Der volle Inhalt der Quelle

Annotation:

Efforts to increase public awareness of the environment can be done through various programs, one of which is through the Corporate Social Responsibility (CSR) program. The implementation of the CSR program can be seen in RW 14, Donan Village, Central Cilacap District, Cilacap Regency. This area is close to the oil and gas company, PT Kilang Pertamina Internasional RU IV Cilacap. This study was conducted to reveal the efforts made by the company to increase public awareness of the surrounding environment. Through field observations and stakeholder interviews. The results of this study mapped e

APA, Harvard, Vancouver, ISO und andere Zitierweisen

16

Fern, Annette. "Re: Sources." Theatre Survey 47, no. 1 (2006): 93–105. http://dx.doi.org/10.1017/s004055740600007x.

Der volle Inhalt der Quelle

Annotation:

In July 2005, the Art Institute of Chicago announced plans for the demolition of the Kenneth Sawyer Goodman Memorial Theatre in order to make room for additional gallery and administrative spaces for the museum. The Goodman Theatre had been a museum department from its founding in 1925 to 2000, when the company became an independent producing organization and moved to a new facility in Chicago's theatre district. Since then, the building had been an unproductive appendage to the Art Institute, but numerous attempts to tear it down had been met with resistance by architectural preservationists

APA, Harvard, Vancouver, ISO und andere Zitierweisen

17

KATRAK, KETU H. "‘Stripping Women of Their Wombs’: Active Witnessing of Performances of Violence." Theatre Research International 39, no. 1 (2014): 31–46. http://dx.doi.org/10.1017/s0307883313000539.

Der volle Inhalt der Quelle

Annotation:

This essay creates a theoretical frame interweaving Jill Dolan's concept of ‘finding hope at the theatre’ with Michel Foucault's concepts of ‘biopower’ and ‘biopolitics’ to argue that spectators’ affective responses to performed violence in live theatre include hope and imagining social change. I draw upon my own active witnessing of theatrical performances of two works –Ruinedby Pulitzer Prize-winning African-American Lynn Nottage, andEncounterby the Indian-American Navarasa Dance Theater Company. Along with Dolan and Foucault, I draw upon affect scholarship by James Thompson and Patricia T.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

18

Rieffel, Marc A. "Representations of *-Algebras, Locally Compact Groups, and Banach *-Algebraic Bundles, I, II. By J. M. G. Fell and R. S. Doran." American Mathematical Monthly 97, no. 2 (1990): 167–70. http://dx.doi.org/10.1080/00029890.1990.11995570.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

19

RAY, SUBHARTHI, JISHNU DEY, and MIRA DEY. "DENSITY DEPENDENT STRONG COUPLING CONSTANT OF QCD DERIVED FROM COMPACT STAR DATA." Modern Physics Letters A 15, no. 20 (2000): 1301–6. http://dx.doi.org/10.1142/s0217732300001626.

Der volle Inhalt der Quelle

Annotation:

Since 1996 there is major influx of X-ray and γ-ray data from binary stars, one or both of which are compact objects that are difficult to explain as neutron stars since they contain a mass M in too small a radius R. The suggestion has been put forward that these are strange quark stars (SS) explainable in a simple model with chiral symmetry restoration (CSR) for the quarks and the M, R and other properties like QPOs (quasi-periodic oscillations) in their X-ray power spectrum. It would be nice if this astrophysical data could shed some light on fundamental properties of quarks obeying QCD. One

APA, Harvard, Vancouver, ISO und andere Zitierweisen

20

Audet, Michel. "Shimon L. DOLAN, Randall S. SCHULER : Canadian Readings in Personnel and Human Resource Management. St-Paul, West Publishing Company, 1987, 467 pp., ISBN 0-314-32487-9." Relations industrielles 43, no. 1 (1988): 203. http://dx.doi.org/10.7202/050400ar.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

21

Kelly, T. "The American Catholic Experience: A History From Colonial Times to the Present. By Jay P. Dolan (Garden City, N.Y.: Doubleday & Company, Inc., 1985. 504 pp. $19.95)." Journal of Social History 21, no. 1 (1987): 153–56. http://dx.doi.org/10.1353/jsh/21.1.153.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

22

Coclanis, Peter A. "Fur, Fortune, and Empire: The Epic History of the Fur Trade in America. By Eric Jay Dolan. (New York, N.Y.: W. W. Norton & Company, 2010. Pp.442. $29.95.)." Historian 73, no. 3 (2011): 555–56. http://dx.doi.org/10.1111/j.1540-6563.2011.00301_5.x.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

23

Cagle, Steven K. "Book Review: The Craniovertebral Junction and Its Abnormalities by John C. VanGilder, Arnold H. Menezes, and Kenneth D. Dolan. Published in 1987 by Futura Publishing Company, Mount Kisco, New York, 251 pages, $65.00." Journal of Child Neurology 4, no. 1 (1989): 75. http://dx.doi.org/10.1177/088307388900400119.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

24

Abbott, Randy L. "Atomic Blonde: The Films of Mamie Van Doren200940Barry Lowe. Atomic Blonde: The Films of Mamie Van Doren. Jefferson, NC: McFarland & Company 2008. viii + 223 pp., ISBN: 978 0 7864 3138 0 $55." Reference Reviews 23, no. 1 (2009): 50–51. http://dx.doi.org/10.1108/09504120910925841.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

25

Hawkins, M. "New Dimensions in American Religious History: Essays in Honor of Martin E. Marty. Edited by Jay P. Dolan and James P. Wind. Grand Rapids, Mich.: William B. Eerdmans Publishing Company, 1993. 340 pp. $29.99." Journal of Church and State 36, no. 4 (1994): 873–74. http://dx.doi.org/10.1093/jcs/36.4.873.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

26

Soumerai, Jacob D., Anthony R. Mato, Ahmet Dogan, et al. "Zanubrutinib, Obinutuzumab, and Venetoclax in Chronic Lymphocytic Leukemia: Early MRD Kinetics Define a High-Risk Patient Cohort with Delayed Bone Marrow Undetectable MRD and Earlier Post-Treatment MRD Recurrence." Blood 138, Supplement 1 (2021): 3753. http://dx.doi.org/10.1182/blood-2021-150961.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: Venetoclax (Ven; BH3 mimetic) and Obinutuzumab (O; CD20 antibody) is an approved, fixed-duration regimen (one year) that induces undetectable minimum residual disease (uMRD) and durable remissions in treatment naïve patients (pts) with chronic lymphocytic leukemia (CLL; Fischer NEJM 2019). In the CLARITY trial of venetoclax-ibrutinib (BTK inhibitor; BTKi) in relapsed or refractory CLL, peripheral blood (PB) MRD response kinetics predicted bone marrow (BM) uMRD and were associated with progression-free survival (Rawstron EHA 2020). We explored MRD as a biomarker to direct t

APA, Harvard, Vancouver, ISO und andere Zitierweisen

27

Kumar, Anita, Jacob D. Soumerai, Jeremy S. Abramson, et al. "Preliminary Safety and Efficacy from a Multicenter, Investigator-Initiated Phase II Study in Untreated TP53 Mutant Mantle Cell Lymphoma with Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen)." Blood 138, Supplement 1 (2021): 3540. http://dx.doi.org/10.1182/blood-2021-151831.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: TP53 mutant mantle cell lymphoma (MCL) is associated with poor survival outcomes with chemoimmunotherapy (Eskelund Blood 2017) and there is no standard frontline treatment for this high-risk patient population. The combination of Bruton's Tyrosine Kinase (BTK) inhibition and the BCL2 inhibition have been shown to be synergistic and active in relapsed, refractory MCL, including in patients with TP53 mutation (Tam NEJM 2018). Obinutuzumab, ibrutinib, and venetoclax has been shown to be well tolerated and associated with high response rates in relapsed and untreated MCL patie

APA, Harvard, Vancouver, ISO und andere Zitierweisen

28

Falchi, Lorenzo, Annie Qiu, Mark D. Ewalt, et al. "Clinical Outcomes and CNS Relapse Risk in Patients with Primary Cutaneous DLBCL, Leg Type Treated in the Rituximab Era: Long-Term Follow-up of a Single-Center Experience." Blood 138, Supplement 1 (2021): 2513. http://dx.doi.org/10.1182/blood-2021-151994.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction: Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL,LT) is a rare subtype of lymphoma that has been reported to have aggressive clinical behavior and carry a poor prognosis. However, due to the extreme scarcity of data, optimal management of this entity remains poorly defined, particularly with respect to optimal induction therapy and the role for central nervous system (CNS) prophylaxis. We therefore reviewed our institutional experience with patients with PCDLBCL,LT to better delineate their clinical course and risk of CNS relapse. Methods: We searched o

APA, Harvard, Vancouver, ISO und andere Zitierweisen

29

Qualls, David, Connie Lee Batlevi, Philip C. Caron, et al. "Favorable Outcomes of Patients with Limited-Stage Ocular Adnexal DLBCL Treated in the Rituximab Era: Long-Term Follow-up of a Single Center Experience." Blood 138, Supplement 1 (2021): 4578. http://dx.doi.org/10.1182/blood-2021-153171.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction Diffuse large B-cell lymphoma of the ocular adnexa (OA-DLBCL) is extremely rare and historically was associated with poor prognosis and higher risk of central nervous system (CNS) relapse. In the rituximab era its prognosis may be more favorable, particularly in individuals with limited-stage disease. However, published series of patients with extranodal limited-stage DLBCL, including a study from our group (Bobillo et al. Blood 2021), rarely included OA-DLBCL. Studies specifically looking at OA-DLBCL reported diverse treatment approaches, including some that are no longe

APA, Harvard, Vancouver, ISO und andere Zitierweisen

30

Sharma, Sunil, and Anuradha R. Chetiya. "Simplifying the Six Sigma Toolbox through Application of Shainin DOE Techniques." Vikalpa: The Journal for Decision Makers 34, no. 1 (2009): 13–30. http://dx.doi.org/10.1177/0256090920090102.

Der volle Inhalt der Quelle

Annotation:

The success of a Six Sigma programme in an organization depends to a large extent on the success of the Six Sigma projects, which in turn depends on how the team handles the problem and whether the right combination of tools is being applied to address the root cause. The Six Sigma toolbox consists of a wide range of tools comprising, on the one hand, simple and commonly used tools like flow charts, Pareto analysis, and cause-and-effect diagram and the more advanced statistical tools like design of experiments, regression analysis and many more, on the other hand. While the simple tools are ea

APA, Harvard, Vancouver, ISO und andere Zitierweisen

31

Budde, L. Elizabeth, Laurie H. Sehn, Matthew J. Matasar, et al. "Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study." Blood 138, Supplement 1 (2021): 127. http://dx.doi.org/10.1182/blood-2021-145872.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: FL is associated with frequent relapses and decreasing progression-free intervals with successive lines of conventional therapy. Later-line treatments may be less effective due to refractory disease. Mosunetuzumab (Mosun) is a CD20xCD3 bispecific antibody (Ab) that redirects T cells to eliminate malignant B cells. In the dose-escalation phase of an ongoing Phase I/II study (NCT02500407), Mosun was highly active and well tolerated in R/R FL patients (pts) who had received ≥2 prior lines of therapy (3L+ R/R FL) when given IV with Cycle (C) 1 step-up dosing for mitigation of

APA, Harvard, Vancouver, ISO und andere Zitierweisen

32

Sermer, David J., Santosha Vardhana, Erin Biggar, et al. "Interim Efficacy Analysis of a Phase II Study Demonstrates Promising Activity of the Combination of Pembrolizumab (PEM) and Entinostat (ENT) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (HL)." Blood 138, Supplement 1 (2021): 2447. http://dx.doi.org/10.1182/blood-2021-154226.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction Histone deacetylase (HDAC) inhibitors have single agent activity in various types of lymphoma. They restore antigen-specific immune recognition in B-cell lymphoma cells and modulate programmed cell death (PD)-1 expression on circulating T-lymphocytes. Pembrolizumab (PEM) is highly active in Hodgkin Lymphoma (HL) and demonstrates a 12-month PFS of 46% in patients with R/R HL. Preclinical studies have shown synergism of this combination in mouse models of various tumors. We present the interim efficacy analysis from the first stage of our phase II trial investigating the co

APA, Harvard, Vancouver, ISO und andere Zitierweisen

33

Harris, Rachel. "Turkestan chinois. Le muqam des Dolan: Musique des Ouïgours du désert de Taklamakan / Chinese Turkestan. The Muqam of the Dolan: Music of the Uighurs from the Taklamakan Desert. 2006. INEDIT / Maison des Cultures du Monde W 260126. Distributed by Naïve. Recorded and annotated by Pierre Bois. 27 pp. of notes in French and English. French translation of lyrics by Mukaddas Mijit. English translation by Frank Kane. 2 colour, 7 b/w photographs. 1 compact disc, 9 tracks (58:45)." Yearbook for Traditional Music 39 (2007): 191–92. http://dx.doi.org/10.1017/s0740155800006901.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

34

Chowdary, Pratima, Susan Shapiro, Mike Makris, et al. "Factor IX Expression within the Normal Range Prevents Spontaneous Bleeds Requiring Treatment Following FLT180a Gene Therapy in Patients with Severe Hemophilia B: Long-Term Follow-up Study of the B-Amaze Program." Blood 138, Supplement 1 (2021): 3967. http://dx.doi.org/10.1182/blood-2021-146546.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction: FLT180a (verbrinacogene setparvovec) is an investigational, liver-directed AAV gene therapy for the treatment of patients with hemophilia B (HB). FLT180a consists of a novel, potent, engineered capsid (AAVS3) containing an expression cassette encoding a Factor IX (FIX) gain-of-function protein variant ('Padua'; FIX-R338L). The B-AMAZE study was designed to identify a dose of FLT180a that maintains FIX activity within the normal range (50-150%) and thereby protect patients with severe HB from spontaneous and traumatic bleeds. Methods: B-AMAZE was a multicentre, open-label

APA, Harvard, Vancouver, ISO und andere Zitierweisen

35

Bal, Susan, Allison Sigler, Alexander Chan, et al. "First Description of B Cell Maturation Antigen Expression in Light Chain Amyloidosis." Blood 134, Supplement_1 (2019): 5452. http://dx.doi.org/10.1182/blood-2019-127332.

Der volle Inhalt der Quelle

Annotation:

Background B-cell maturation antigen (BCMA) is a transmembrane protein belonging to the tumor necrosis factor (TNF) superfamily involved in the regulation of B cell proliferation and survival as well as maturation/differentiation into plasma cells. In multiple myeloma cells, overexpression of BCMA has been shown to activate mitogen activated protein kinase pathways (AKT, ERK1/2, and NF-κB) and upregulates anti-apoptotic proteins (MCL1, BCL2, BCL-xL) resulting in cellular proliferation. Immunotherapeutic strategies targeting BCMA are showing great promise in heavily pre-treated refractory multi

APA, Harvard, Vancouver, ISO und andere Zitierweisen

36

Mailankody, Sham, Claudia Diamonte, Lisa Fitzgerald, et al. "Phase I First-in-Class Trial of MCARH109, a G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) Targeted CAR T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma." Blood 138, Supplement 1 (2021): 827. http://dx.doi.org/10.1182/blood-2021-153204.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: BCMA targeted CAR T cell therapy has shown promising results in patients with relapsed/refractory multiple myeloma (RRMM), but relapses are common. Additional treatment options with novel therapeutic targets or mechanisms of action are needed. Here we report on the safety and efficacy of MCARH109, the first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) targeted CAR T cell therapy (Smith EL et al. Sci. Trans Med 2019) in RRMM including patients who relapsed post BCMA targeted CAR T cell therapy. Methods: This is a phase I first-in-human, dose escalat

APA, Harvard, Vancouver, ISO und andere Zitierweisen

37

Maura, Francesco, Eileen M. Boyle, Benjamin Diamond, et al. "Genomic and Immune Signatures Predict Sustained MRD Negativity in Newly Diagnosed Multiple Myeloma Patients Treated with Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone (D-KRd)." Blood 138, Supplement 1 (2021): 325. http://dx.doi.org/10.1182/blood-2021-149112.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction: Treatment combinations involving CD38 targeted monoclonal antibodies have significantly prolonged the median duration and depth of response in myeloma (MM), reflected in minimal residual disease-negativity (MRD-) rates of over 70% in newly diagnosed patients (Landgren et al. JAMA Onc 2021). Key to improving our understanding of treatment failures is the combined use of single cell analysis of the microenvironment with genome wide assessment of tumor genetics to decipher the mechanisms of disease resistance. Methods: We isolated malignant plasma cells from bone marrow (BM

APA, Harvard, Vancouver, ISO und andere Zitierweisen

38

Launonen, Aino, Rodrigo Ho, Andrea Knapp, Irene Canales Ruiz, Leonardo Simonella, and Per-Olof Thuresson. "Exploring the Impact of Diffuse Large B-Cell Lymphoma (International Prognostic Index [IPI] 2-5) on Clinical and Patient-Relevant Outcomes in the Context of a Clinical Trial." Blood 138, Supplement 1 (2021): 3577. http://dx.doi.org/10.1182/blood-2021-146822.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: Most patients (pts) with diffuse large B-cell lymphoma (DLBCL) receiving first-line (1L) rituximab plus CHOP (R-CHOP) have similar mortality to the general population (gen popn) if they are progression-free at 24 months (PFS24; Maurer et al. Ann Oncol 2018). Characterization of quality of life (QoL) and clinical outcomes may enable more patient-relevant treatment decisions. Using GOYA trial data (NCT01287741) comparing obinutuzumab (G) + CHOP (G-CHOP) with R-CHOP, we present an exploratory analysis of 1L DLBCL pts with IPI 2-5 and assess overall survival (OS) and QoL relat

APA, Harvard, Vancouver, ISO und andere Zitierweisen

39

Maclachlan, Kylee H., Tina Bagratuni, Efstathios Kastritis, et al. "The Genomic Landscape of Waldenström Macroglobulinemia Reveals Sustained Germinal Center Activity and Late-Developing Copy Number Aberrations." Blood 138, Supplement 1 (2021): 2394. http://dx.doi.org/10.1182/blood-2021-148095.

Der volle Inhalt der Quelle

Annotation:

Abstract The genomic landscape of Waldenström Macroglobulinemia (WM) is characterized by recurrent somatic mutations in MYD88, with a lower incidence of mutations affecting CXCR4, ARID1A, CD79B and the NFKB signaling pathway (Hunter et. al. Blood 2014). We aimed to characterize the relationship between single base substitutions (SBS), mutational signatures, copy number aberrations (CNA) and structural variants (SV) in WM. We performed whole genome sequencing (WGS) on 14 primary samples from WM patients at various clinical stages, including IgM monoclonal gammopathy (n=1), smoldering (n=5), new

APA, Harvard, Vancouver, ISO und andere Zitierweisen

40

Dewitt, Mark F. "The Carrière Brothers: Old Time Louisiana Creole Music. 2004. Arhoolie CD 512. Performed by Joseph “Bébé” and Éraste “Dolan” Carrière. Recorded by Chris Strachwitz. Annotated by Ron and Fay Stanford, with additional comments by Ann Savoy. 7 pages of notes in English. 3 B/W photographs. 1 compact disc, 20 tracks (46:54). Recorded in 1974; 9 tracks previously released on Arhoolie LP 5031, 11 previously unissued. - The Best of Clifton Chenier: The King of Zydeco and Louisiana Blues. 2003. Arhoolie CD 474. Reissue produced and annotated by Chris Strachwitz. 13 pages of notes in English. 1 colour, 5 B/W photographs. 1 compact disc, 18 tracks (77:15). Reissue of original recordings released between 1964 and 1983." Yearbook for Traditional Music 36 (2004): 190–91. http://dx.doi.org/10.1017/s0740155800020646.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

41

Moskowitz, Alison J., Raphael Koch, Neha Mehta-Shah та ін. "In Vitro, In Vivo, and Parallel Phase I Evidence Support the Safety and Activity of Duvelisib, a PI3K-δ,γ Inhibitor, in Combination with Romidepsin or Bortezomib in Relapsed/Refractory T-Cell Lymphoma". Blood 130, Suppl_1 (2017): 819. http://dx.doi.org/10.1182/blood.v130.suppl_1.819.819.

Der volle Inhalt der Quelle

Annotation:

Abstract Introduction: Current therapies for relapsed/refractory (rel/ref) T-cell lymphomas (TCLs) induce responses in only 25-30% of patients (pts). Phosphoinositide-3-kinases (PI3K) play a pivotal role in cell signaling and PI3K isoforms have distinct roles in the development, function and survival of T cells. A phase I study of the oral PI3K-δ/γ inhibitor duvelisib (DUV) in pts with TCLs showed promising activity in rel/ref TCL (Horwitz, Blood 2014). We assessed mechanisms of response and resistance to DUV in T-cell lymphomas in vitro and in vivo. Based on in vitro evidence of synergy, we i

APA, Harvard, Vancouver, ISO und andere Zitierweisen

42

Mehta-Shah, Neha, Alison J. Moskowitz, Matthew A. Lunning, et al. "A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B- and T-Cell Lymphomas." Blood 130, Suppl_1 (2017): 821. http://dx.doi.org/10.1182/blood.v130.suppl_1.821.821.

Der volle Inhalt der Quelle

Annotation:

Abstract Background: Epigenetic manipulation and immunomodulation are therapeutic strategies in hematologic malignancies. In our previous study, the combination of romidepsin and lenalidomide showed a 51% overall response rate (ORR), 23% complete response (CR) rate in patients with relapsed/ refractory B-cell (BCL) and T-cell (TCL) lymphoma. Given the potential synergy of proteasome inhibitors with histone deacetylase inhibitors and lenalidomide, we conducted a phase Ib/IIa study evaluating the safety and toxicity of romidepsin and lenalidomide with carfilzomib in patients with relapsed/refrac

APA, Harvard, Vancouver, ISO und andere Zitierweisen

43

Fauzi, Chandra, and Basikin. "The Impact of the Whole Language Approach Towards Children Early Reading and Writing in English." JPUD - Jurnal Pendidikan Usia Dini 14, no. 1 (2020): 87–101. http://dx.doi.org/10.21009/jpud.141.07.

Der volle Inhalt der Quelle

Annotation:

   This study aims to determine the effect of the whole language approach to the ability to read and write in English in early stages of children aged 5-6 years in one of the kindergartens in the Yogyakarta Special Region. The population in this study were 43 children who were in the age range of 5-6 years in the kindergarten. Twenty-nine participants were included in the experimental class subjects as well as the control class with posttest only control group design. Observation is a way to record data in research on early reading and writing ability. The results of Multivar

APA, Harvard, Vancouver, ISO und andere Zitierweisen

44

Seeff, Adele. "Titus Andronicus: South Africa's Shakespeare." Borrowers and Lenders The Journal of Shakespeare Appropriations 4, no. 1 (2023). https://doi.org/10.18274/ktlw9951.

Der volle Inhalt der Quelle

Annotation:

One of the more interesting examples of the global circulation of texts and productions is the Antony Sher-Gregory Doran 1995 production of Titus Andronicus at the Market Theatre, Johannesburg. Gregory Doran, an English actor/director with experience at the Royal Shakespeare Company, made the decision to direct the play with Antony Sher as Titus during a visit by the Royal National Theatre's Studio in September 1994, just months after the first democratic elections in post-apartheid South Africa. In this paper, I argue that Doran, who cast his production as a conflict between extreme right-win

APA, Harvard, Vancouver, ISO und andere Zitierweisen

45

Yorkinova, Marguba Yaxiyayevna. "WAYS TO INCREASE ENTERPRISE PROFIT IN MODERN CONDITIONS." May 29, 2024. https://doi.org/10.5281/zenodo.11382508.

Der volle Inhalt der Quelle

Annotation:

The knowledge of business landscape helps people to understand the given opportunities and threats. Every company is a part of one or more segments of a business and these segments are known as industries. For example, my own company is a part of the cosmetic industry. As stated by FCIB (2015), the political and economic life of a country in which a business operates always has a big impact on the performance of that business. Furthermore, the social life and the natural environment in that country also have an equal impact on the profitability of that business. In the USA, people always prefe

APA, Harvard, Vancouver, ISO und andere Zitierweisen

46

Schoofs, Till, Brooke A. Bollman, Kevin Mancini, et al. "575. Safety and Immunogenicity of mRNA-1403, a Multivalent Norovirus mRNA Vaccine, in Healthy Adults: Interim Results of a Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial." Open Forum Infectious Diseases 12, Supplement_1 (2025). https://doi.org/10.1093/ofid/ofae631.013.

Der volle Inhalt der Quelle

Annotation:

Abstract Background Norovirus (NoV) is a leading cause of acute gastroenteritis worldwide and is associated with significant disease burden across all ages. Currently, there is no licensed NoV vaccine. NoV’s high genetic diversity coupled with genotype-specific immune responses indicate that a multivalent approach may be required to generate a broadly protective vaccine. A trivalent mRNA-based NoV vaccine candidate (mRNA-1403), consisting of mRNAs encoding for the major capsid protein (VP1) of 3 globally prevalent NoV genotypes (GII.4, GI.3 and GII.3) formulated in a lipid nanoparticle, is in

APA, Harvard, Vancouver, ISO und andere Zitierweisen

47

Thom, Alexander. "Review of Shakespeare’s Cymbeline (Directed by Gregory Doran for the Royal Shakespeare Company) at the Royal Shakespeare Theatre, Stratford-upon-Avon, 23 May 2023." Shakespeare, June 16, 2023, 1–3. http://dx.doi.org/10.1080/17450918.2023.2224288.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

48

Greb, Daniel, and Christian Miebach. "Hamiltonian actions of unipotent groups on compact K\"ahler manifolds." Épijournal de Géométrie Algébrique Volume 2 (November 9, 2018). http://dx.doi.org/10.46298/epiga.2018.volume2.4486.

Der volle Inhalt der Quelle

Annotation:

We study meromorphic actions of unipotent complex Lie groups on compact K\"ahler manifolds using moment map techniques. We introduce natural stability conditions and show that sets of semistable points are Zariski-open and admit geometric quotients that carry compactifiable K\"ahler structures obtained by symplectic reduction. The relation of our complex-analytic theory to the work of Doran--Kirwan regarding the Geometric Invariant Theory of unipotent group actions on projective varieties is discussed in detail. Comment: v2: 30 pages, final version as accepted by EPIGA

APA, Harvard, Vancouver, ISO und andere Zitierweisen

49

CANBOLAT, Ferhat, and Günhan GÖNÜL KOŞAR. "CONTRIBUTORY FAULT AND ITS ASSESSMENT IN THE LIABILTY OF THE INSURANCE COMPANY ARISING FROM THE OPERATION OF THE MOTOR VEHICLE." Hacettepe Hukuk Fakültesi Dergisi, August 2, 2022. http://dx.doi.org/10.32957/hacettepehdf.1114338.

Der volle Inhalt der Quelle

Annotation:

Highway Traffic Act Art. 85/1 stipulates dangerous liability, a strict liability regime, for the damage arising from the operation of motor vehicle. Insurance company is liable up to a certain amount for the damage that falls withing the scope of Highway Traffic Act Art. 85/1. Insurance company cannot claim for a reduction in the amount of compensation on the ground that the driver/operator of the vehicle is not at fault/mild fault. It is not only meaningless for insurance companies to claim that the driver is not at fault, but also declaring that the driver is at fault with a certain rate (30

APA, Harvard, Vancouver, ISO und andere Zitierweisen

50

Dorman, Rachel, Lisa M. Leslie, Michael S. Gutter, Martie Gillen, and Josephine Turner. "Individual Retirement Accounts." EDIS 2012, no. 5 (2012). http://dx.doi.org/10.32473/edis-fy642-2012.

Der volle Inhalt der Quelle

Annotation:

An individual retirement account (IRA) is a good tool to build retirement funds. This type of account has been offered since 1974 and comes with special tax advantages. An IRA can be opened through a financial institution such as a bank, credit union, mutual fund company, or brokerage firm. Learn more in this revised 4-page fact sheet written by Rachel Dorman, Lisa M. Leslie, Michael S. Gutter, Martie Gillen, and Josephine Turner, and published by the UF Department of Family, Youth and Community Sciences, April 2012.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!